Herold Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-378
Closed -$234K 281
2024
Q3
$234K Hold
378
0.05% 245
2024
Q2
$209K Hold
378
0.05% 247
2024
Q1
$220K Sell
378
-1,351
-78% -$758K 0.05% 245
2023
Q4
$918K Buy
1,729
+240
+16% +$116K 0.25% 114
2023
Q3
$754K Buy
1,489
+279
+23% +$149K 0.23% 124
2023
Q2
$631K Buy
1,210
+164
+16% +$88.5K 0.19% 132
2023
Q1
$603K Buy
1,046
+611
+140% +$344K 0.21% 121
2022
Q4
$240K Hold
435
0.1% 181
2022
Q3
$220K Hold
435
0.11% 173
2022
Q2
$236K Buy
435
+65
+18% +$35.8K 0.11% 178
2022
Q1
$219K Buy
+370
New +$213K 0.08% 187

Other funds holding TMO

Herold Advisors's TMO Position: Q4 2024 in Review

Herold Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 378 shares — an estimated $234K sold.

Herold Advisors first reported a position in TMO in Q1 2022 and held it in 11 quarters. The position peaked at $918K in Q4 2023. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Herold Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Herold Advisors sold 378 Thermo Fisher Scientific shares in Q4 2024, an estimated $234K.
  • Herold Advisors first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 11 quarters.
  • Herold Advisors's Thermo Fisher Scientific position peaked at $918K in Q4 2023.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Herold Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.